Vanberra Signal
Free trial

SynDiag

Curated by Signal

Provider of AI based software for early ovarian cancer diagnosis

Health Technologysyndiag.ai

Overview

SynDiag develops AI-based software for early ovarian cancer diagnosis. The features of the software, access to a complete ultrasound scan database of adnexal masses collected by international reference healthcare centers. The software provides an interpretation of ultrasound scans that highlights cancer signs accordingly to IOTA guidelines. It can be configured for any ultrasound machine and provide real-time a second-opinion about adnexal masses features.

Key facts

Founded
2017
Headquarters
Turin, Italy
Stage
Sign up to view
Industry
Health Technology

Business model

1 product or service
Sign up to view

Contact

Primary office
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • IntendiMe

    Sensor-based hearing aids

    Health TechnologyCagliari, Italy

  • PharmAround

    Provider of a mobile application for travelers to discover and book services at pharmacies

    Health TechnologyAltavilla Vicentina, Italy

  • INTENSIVE21

    Online platform offering nutrition programs for weight loss

    Health TechnologyMilan, Italy

About SynDiag

What does SynDiag do?

SynDiag develops AI-based software for early ovarian cancer diagnosis.

Where is SynDiag headquartered?

SynDiag is headquartered in Turin, Italy.

When was SynDiag founded?

SynDiag was founded in 2017.

Which sector is SynDiag in?

SynDiag operates in Health Technology.

Who are SynDiag's competitors?

Companies similar to SynDiag include IntendiMe, PharmAround, and INTENSIVE21.